National Cross-Sectional Study of Community-Based Adverse Drug Reactions in Saudi Arabia
Open Access
- 25 March 2020
- journal article
- research article
- Published by Springer Nature in Drugs - Real World Outcomes
- Vol. 7 (2) , 161-170
Abstract
Background An adverse drug reaction (ADR) is a response to a medicine that is not intended and is harmful, and which occurs at normal dose levels for humans. Currently, there are no estimates of the population-based prevalence of ADRs in the Kingdom of Saudi Arabia (KSA). Objective The aims of this study were to (1) estimate the population-based prevalence of ADRs in KSA, (2) describe the ADRs experienced by survey respondents, and (3) investigate the level of awareness of the ADR reporting system. Patients and Methods This was a cross-sectional survey using stratified, population-based sampling conducted at a chain of community pharmacies. Results Analysis was conducted on 5228 surveys; 50.17% of respondents were males, and the mean age was 39 ± 15 years (min = 18, max = 98). The sample prevalence of ADRs was 23.45% (95% CI 22.30–24.60%, P < 0.001). The estimated population prevalence (after weighting) was 28.00% (26.10–30.00%). Gastrointestinal disorders were the most commonly reported ADRs (58.73%), followed by general disorders and administration site conditions (19.74%). The largest drug class that was reported to lead to ADRs was nonsteroidal anti-inflammatory drugs (NSAIDs) (11%). Over 19% of the respondents who experienced an ADR required medical intervention to control the suffering induced by the ADR. Of the respondents who experienced an ADR, 371 (30.26%) were aware of the ADR reporting system but only 53 (14.29%) said that they had filed a report in the system. Conclusions Our study estimated that 28% of the population experienced an ADR over a 1-year period in KSA. Risk factors for ADR included certain chronic disease groups and the use of certain classes of medications. Regulatory authorities in KSA intend to conduct more research and deploy educational interventions to reduce ADR rates in KSA. This will hopefully occur in an international context that promotes the standardized measurement of ADRs in the community. A subset of findings from this report was presented in an oral presentation at the Saudi Food and Drug Authority (SFDA) Annual Conference, September 27, 2018. In addition, a subset of findings from this report were presented on a poster at the International Conference of Pharmacoepidemiology and Therapeutic Risk Management (ICPE), August 27, 2019.Keywords
This publication has 21 references indexed in Scilit:
- A qualitative exploration of the major challenges facing pharmacovigilance in Saudi ArabiaSaudi Medical Journal, 2015
- Completeness of adverse drug reactions reports of the Saudi adverse event reporting systemSaudi Medical Journal, 2015
- A systematic review of the prevalence and risk factors for adverse drug reactions in the elderly in the acute care settingClinical Interventions in Aging, 2014
- Improvement of patient adverse drug reaction reporting through a community pharmacist-based intervention in the Campania region of ItalyExpert Opinion on Drug Safety, 2014
- Prevalence and Perceived Preventability of Self-Reported Adverse Drug Events – A Population-Based Survey of 7099 AdultsPLOS ONE, 2013
- Effect of Pharmacist Involvement on Patient Reporting of Adverse Drug Reactions: First Italian StudyDrug Safety, 2013
- Adverse Drug Reaction Deaths Reported in United States Vital Statistics, 1999-2006Annals of Pharmacotherapy, 2012
- Consumers' reports of suspected adverse drug reactions volunteered to a consumer magazineBritish Journal of Clinical Pharmacology, 2010
- Trends in hospital admissions for adverse drug reactions in England: analysis of national hospital episode statistics 1998–2005BMC Clinical Pharmacology, 2007
- Adverse drug reactions as cause of admission to hospital: prospective analysis of 18 820 patientsBMJ, 2004